It is now nearly a quarter of a century since the Human Genome Project concluded in celebration at biology’s arrival as Big Science and optimism about its revolutionary implications for healthcare. It ...

A shift in focus to more personalised and preventative approaches to health has the potential to enable people to live healthier lives for longer. The incorporation of new health technologies and the ...

Laura is PHG Foundation’s Head of Science, and is responsible for the delivery of the scientific expertise and analysis that underpin our work. She also contributes to the development of our strategic ...

Antimicrobial resistance (AMR) is one of the greatest challenges facing health systems, causing an estimated 4.71 million deaths globally in 2021. It has been ten years since the World Health ...

In Host genomics: lessons for infectious disease, we explore the potential of this complex field in tackling infectious disease. Based on our investigation of four major pathogens, we make ...

There is growing evidence that climate change adversely affects human health. Multiple diseases are sensitive to climate change, many of which are also leading causes of death globally. Despite this ...

Between 4-7 October 2016, a group of invited international experts in health, public policy, public health, law and ethics assembled at Ickworth House, (Suffolk, UK) for a meeting entitled ...

Developments in biological and informational technology are significantly advancing our understanding of health and disease and of how to preserve, improve and restore wellbeing. Implementing new ...

Future improvements in population health will be underpinned by data. The accelerating rate of data generation, increase in computing power and the growth in capability of AI and digital technology ...

Mike grew up in the Seattle area before beginning undergraduate study in 1999 at the University of Washington, where he graduated with BSc’s in biochemistry and economics. As a 19 year-old, Mike began ...

Heather is a biomedical policy analyst who first developed an interest in policy when exploring the evidence base for secondary findings and associated risk estimates in individuals with and without a ...